PDE - 5抑制剂
Search documents
揭秘「伟哥」背后,多数人不知道的商业故事
36氪· 2025-10-30 13:37
Core Viewpoint - The article discusses the confusion and risks associated with the purchase of erectile dysfunction (ED) medications, particularly focusing on the brand name "Viagra" and its misuse in the market, leading to consumer deception and health risks [2][9][50]. Group 1: Market Confusion - The term "伟哥" (Weige) has become a generic term for ED medications in China, leading to a proliferation of misleading products and advertisements [21][32]. - A significant portion of complaints related to "伟哥" includes false advertising (28%), product mismatches (20%), and counterfeit or unregulated products (19%) [9][45]. - The commercialization of "伟哥" has resulted in a disconnect between the original drug, Viagra, and the various products marketed under the same name, creating a chaotic marketplace [20][40]. Group 2: Historical Context - Viagra, originally approved by the FDA in 1998 as a cardiovascular drug, became the first oral PDE-5 inhibitor for ED treatment, significantly impacting both medical and cultural perceptions [15][18]. - The introduction of Viagra to the Chinese market in 2000 marked the beginning of a complex relationship between the drug's medical use and its cultural symbolism [19][20]. - The brand name "万艾可" (Wan Aike) was established for Viagra in China, while "伟哥" became a separate trademark owned by a domestic company, leading to brand confusion [25][36]. Group 3: Regulatory and Legal Issues - Legal disputes have arisen over whether "伟哥" should be considered a generic term, with the National Intellectual Property Administration ruling that it retains its trademark status [38]. - Pfizer has attempted to assert that "伟哥" is a well-known trademark, but courts have not consistently supported this claim [39][40]. - The fragmentation of trademark rights has contributed to ongoing brand confusion and legal challenges in the market [37]. Group 4: Consumer Risks - Consumers face significant risks when purchasing ED medications online, including exposure to counterfeit products and unregulated substances that may contain harmful ingredients [46][59]. - The lack of clear labeling and the prevalence of misleading marketing tactics complicate the consumer's ability to make informed choices [44][45]. - The article emphasizes the importance of purchasing medications through legitimate channels and verifying product authenticity to mitigate health risks [54][60].
揭秘:多数人不知道的“伟哥”背后的商业故事——被误读的药,被利用的名字,和被忽视的风险
Di Yi Cai Jing· 2025-10-27 00:03
Core Insights - The article discusses the confusion and risks surrounding the purchase of erectile dysfunction (ED) medications, particularly focusing on the brand "Viagra" and its generic name "Sildenafil Citrate" [2][4][12] - It highlights the cultural significance of the "blue pill" and how it has become a symbol in popular culture, while also being a serious medical treatment [2][4] - The article emphasizes the importance of proper medical guidance and the dangers of self-medication in a market filled with counterfeit and misleading products [10][11][12] Group 1: Market Confusion - The term "伟哥" (Wei Ge) has become a generic term in China, leading to significant brand confusion and a proliferation of counterfeit products [3][6][7] - Data from the Black Cat Complaints platform indicates that approximately 28% of complaints related to "伟哥" involve false advertising, while 20% pertain to product discrepancies, and nearly 19% involve counterfeit or unregulated products [1][6] - The commercialization of "伟哥" has led to a market where legitimate products are often indistinguishable from fake ones, creating a high-risk environment for consumers [5][8] Group 2: Regulatory and Legal Issues - The trademark status of "伟哥" has led to legal disputes, with the National Intellectual Property Administration ruling that it retains its distinctiveness and does not constitute a generic term [6][7] - Pfizer's claim that "伟哥" is a well-known trademark was not supported by the Beijing First Intermediate People's Court, further complicating the brand's legal standing in China [7] - The division of trademark rights across different regions (e.g., Hong Kong, Taiwan, and mainland China) has contributed to the confusion and legal complexities surrounding the brand [6][7] Group 3: Health Risks and Consumer Education - The article stresses the necessity for consumers to recognize the difference between prescription medications and over-the-counter products, emphasizing that PDE-5 inhibitors like Sildenafil should only be used under medical supervision [10][11] - Consumers are advised to verify the legitimacy of medications by checking for proper approval numbers and ensuring they are purchased from regulated channels [10][11] - The prevalence of illegal products that masquerade as health supplements poses serious health risks, particularly due to uncontrolled dosages and potential harmful ingredients [11][12]